References
- de Leval L, Gisselbrecht C, Gaulard P. Advances in the understanding and management of angioimmunoblastic T-cell lymphoma. Br J Haematol. 2010;148:673–689.
- Dunleavy K, Wilson WH, Jaffe ES. Angioimmunoblastic T cell lymphoma: pathobiological insights and clinical implications. Curr Opin Hematol. 2007;14:348–353.
- Allen-Auerbach M, de Vos S, Czernin J. The impact of fluorodeoxyglucose-positron emission tomography in primary staging and patient management in lymphoma patients. Radiol Clin North Am. 2008;46:199–211.
- Terasawa T, Nihashi T, Hotta T, et al. 18F-FDG PET for posttherapy assessment of Hodgkin’s disease and aggressive non-Hodgkin’s lymphoma: a systematic review. J Nucl Med. 2008;49:13–21.
- Bass JC, Korobkin MT, Cooper KD, et al. Cutaneous T-cell lymphoma: CT in evaluation and staging. Radiology. 1993;186:273–278.
- Howlett DC, Wong WL, Smith NP, et al. Computed tomography in the evaluation of cutaneous T-cell lymphoma. Eur J Radiol. 1995;20:39–42.
- Cho YU, Chi HS, Park CJ, et al. Distinct features of angioimmunoblastic T-cell lymphoma with bone marrow involvement. Am J Clin Pathol. 2009;131:640–646.
- Jacobson RK1, Lee KC, Muglia JJ, et al. Cutaneous manifestations of angioimmunoblastic T-cell lymphoma. J Am Acad Dermatol. 2013;69:e25–e26.
- Alcorn FS, Mategrano VC, Petasnick JP, et al. Contributions of computed tomography in the staging and management of malignant lymphoma. Radiology. 1977;125:717–723.
- Weiler-Sagie M, Busheler O, Epelbaum R, et al. 18F-FDG avidity in lymphoma readdresed: a study of 766 patients. J Nucl Med. 2010;51:25–30.
- Friedberg JW, Chengazi V. PET scans in the staging of lymphoma: current status. Oncologist. 2003;8:438–447.
- Cheson BD. Role of functional imaging in the management of lymphoma. J Clin Oncol. 2011;29:1844–1854.
- Hernandez-Maraver D, Hernandez-Navarro F, Gomez-Leon N, et al. positron emission tomography/computed tomography: diagnostic accuracy in lymphoma. Br J Haematol. 2006;135:293–302.